Rockville company working on HIV cure will go public

Rockville, Maryland-based American Gene Technologies International will spin off is Addimmune division as a publicly traded company through a special purpose acquisition company. Addimmune is developing a gene and cell therapy that make gene modifications to T-cells that harden those cells against HIV infection and depletion, and that may allow those cells to target and kill HIV, the precursor to AIDS, instead of being killed by the virus.